MedPath

The Effect of switch from Febuxostat to Dotinurad on the serum levels of indoxyl sulfate in patients with chronic kidney

Not Applicable
Recruiting
Conditions
Hyperuricemia Chronic kidney disease
Registration Number
JPRN-UMIN000046180
Lead Sponsor
Oita University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) severe heart failure (NYHA>2) 2) a patient taking oral statin 3) Liver dysfunction (Child Pugh - Grade B or C) 4) Allergy 5) a patient with chronic inflammatory disease taking NSAIDs, steroid and immunosuppressants. 6) a patient who is considered ineligible for enrolling the study by a principal investigator or sub-investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath